Lawyers representing both sides in concussion lawsuits against sports leagues may eventually have a new tool at their disposal: a diagnostic signature that uses artificial intelligence to detect brain trauma years after it has occurred.
A generous donation by The Tenaquip Foundation will improve the quality of care available to ALS patients at The Neuro, and increase the rate at which researchers can evaluate new ALS drugs.
Patients with common widespread forms of cancer will enjoy longer life expectancy and reduced risk of recurrence thanks to a multimodal optical spectroscopy probe developed by Canadian researchers.
Scientists have known for some time that a memory is stored in the brain through changes in the strength of particular synapses, the structures that pass signals between neurons. However, how the change in strength persisted remained a mystery. Solving this mystery has important implications for remedying neurological and psychological disorders.
The article below provides insights from Dr. Mark O'Malley, an ICUF Visiting Professor with McGill University's Trottier Institute for Sustainability in Engineering and Design (TISED). Dr. O'Malley (from University College Dublin) coordinated the recently released EASAC's policy-related report on "Valuing dedicated storage in electricity grids".
Traumatic brain injury is a life-threatening condition that requires fast and accurate intervention. A protocol for a new tool developed by Medtronic Navigation with the help of researchers at the McGill University Health Centre (MUHC) is allowing surgeons to deliver better care than ever.
When NHL star player Sidney Crosby suffered a concussion during a game in May – the fourth concussion of his career – the news made nationwide headlines. A few years earlier, a concussion had kept the Pittsburgh Penguins star off the ice for ten months.
Concussions can have serious consequences, even in cases where the victim shows few symptoms immediately. Victims often shrug off a mild blow to the head, unaware that brain damage has occurred.
ALS takes away the patient’s motor functions one at a time, and the progress of finding effective drugs to counter its insidious effects has been slow. June is ALS Month, a good time to update the public on the latest developments in ALS research taking place at The Neuro.
The Montreal Neurological Institute and Hospital (The Neuro) is recognized as a leading Canadian centre for research into amyotrophic lateral sclerosis (ALS) as well as for its care of ALS patients.
The Montreal Neurological Institute (The Neuro) is marking Stroke Month in June to increase public awareness about the dangers of this serious condition, and the importance of early intervention. A Canadian suffers a stroke every ten minutes. Each year, about 14,000 Canadians die of stroke, making stroke the third-leading cause of death in this country.
The quest for better understanding of Alzheimer’s disease (AD) has a powerful new tool at its disposal — the ability to artificially generate brain cells that have been shown to play an important role in the disease function.
**This message is sent on behalf of Yves Beauchamp, Vice-Principal (Administration and Finance) and Rose Goldstein, Vice-Principal (Research and Innovation)
Dear Colleagues,
The Montreal Neurological Institute and Hospital (The Neuro) is home to Canada’s first multiple sclerosis (MS) clinic, and MS research and treatment has been a major focus at The Neuro for many years. The MS clinic employs a highly specialized staff who have access to the latest research data and methods of treatment. It is a clinic where innovation and progress are paramount.
Brain diseases and disorders are the leading cause of disability, directly affecting one in three Canadians as well as millions of family members, friends, colleagues and caregivers. The Government of Canada recognizes the significant impact on the health of Canadians, and supports Canadian research on the brain and related diseases and disorders
The ability to remember sounds, and manipulate them in our minds, is incredibly important to our daily lives — without it we would not be able to understand a sentence, or do simple arithmetic. New research is shedding light on how sound memory works in the brain, and is even demonstrating a means to improve it.
March 26 is Purple Day for Epilepsy, a day to support epilepsy awareness worldwide
The Neuro has been a world leader in epilepsy treatment and research for more than 60 years. Indeed, the “Montreal Procedure” developed by The Neuro’s founder, Dr. Wilder Penfield, and his colleagues has become the standard operating procedure for the surgical treatment of epilepsy. The Neuro was also a pioneering institute in exploiting electroencephalography (EEG) and magnetic resonance imaging (MRI) to study and treat epilepsy.
